The first 25 N-terminal amino acids of the major outer membrane protein of Chlamydia trachomatis serovar L2 were determined. The amino acid sequence was used to construct an oligonucleotide probe specific for the major outer membrane protein gene. Using this oligonucleotide as a hybridization probe, we discovered one recombinant clone that produced a 15-kilodalton polypeptide which reacted with a monoclonal antibody directed against the major outer membrane protein type-specific epitope. In a separate set of experiments, we uncovered another recombinant clone that produced a 51-kilodalton polypeptide which was reactive with an anti-major outer membrane protein subspecies-specific monoclonal antibody. The expression of these recombinant DNA plasmids in Escherichia coli is discussed.
The first 25 N-terminal amino acids of the major outer membrane protein of Chlamydia trachomatis serovar L2 were determined. The amino acid sequence was used to construct an oligonucleotide probe specific for the major outer membrane protein gene. Using this oligonucleotide as a hybridization probe, we discovered one recombinant clone that produced a 15-kilodalton polypeptide which reacted with a monoclonal antibody directed against the major outer membrane protein type-specific epitope. In a separate set of experiments, we uncovered another recombinant clone that produced a 51-kilodalton polypeptide which was reactive with an anti-major outer membrane protein subspecies-specific monoclonal antibody. The expression of these recombinant DNA plasmids in Escherichia coli is discussed.
Members of the genus Chlamydia are obligately intracellular procaryotes that have many characteristics resembling those of gram-negative bacteria (for reviews, see references 3 and 31). There are three Chlamydia trachomatis biovars, two of which exclusively infect humans. On the other hand, the many types of Chlamydia psittaci strains are parasites of a variety of animal species. Although the life cycles of all chlamydiae are similar, it is clear that C. trachomatis is not closely related to C. psittaci, as determined by DNA relatedness (24, 30) . Whether these two species have a common ancestor or whether they are the result of convergent evolution is not clear.
The life cycles of chlamydiae involve the following two forms: metabolically dormant elementary bodies (EBs) and vegetative reticulate bodies. The EBs are able to interact with the surface of a host cell and promote phagocytosis. After engulfment, chlamydial EBs transform into reticulate bodies, grow within the phagosome, and inhibit fusion of the phagosome with the lysosome. After approximately seven rounds of division, the chlamydiae begin to differentiate into EBs prior to release.
It has been postulated that the surface components of C. trachomatis play a role in the stimulation of phagocytosis (4) and in the inhibition of phagosome-lysosome fusion (17) . Although lipopolysaccharide and a number of outer membrane polypeptides can be separated and identified by polyacrylamide gel electrophoresis (PAGE) (5, 7), functional roles can be assigned to perhaps a few proteins, most notably the major outer membrane protein (MOMP) (2) . This protein, which comprises up to 60% by weight of the outer membrane proteins (7) , functions both as a structural component (2) and as a porin (2) . The MOMP is covalently linked through disulfide cross-bridging to itself and other outer membrane proteins (2, 21, 28 ). This disulfide cross-bridging is thought to provide the structural stability to the EB outer membrane, which in turn maintains the rigidity of the EB in the absence of a peptidoglycan (2, 21, 28 tion of MOMP disulfide bonds has been proposed as a triggering mechanism that initiates the primary differentiation step of EBs to reticulate bodies (19) . In addition, reduction of MOMP seems to regulate its porin function (2) . These important biological functions are common to the MOMPs of all chlamydiae, suggesting that these proteins are related evolutionarily despite the apparent lack of genetic relatedness among the chlamydial species. The fact that there is little antigenic (6) or structural relatedness between the MOMPs of C. trachomatis and C. psittaci indicates that the common functions may reside in small, highly conserved portions of the proteins or that the MOMPs have diverged at the level of primary amino acid sequences while maintaining similar secondary or tertiary structures.
In addition to these biological features, the MOMP is an important chlamydial antigen. It is the predominant serotyping antigen of C. trachomatis isolates (9, 33) , and polyclonal antibody (8) , as well as monoclonal antibody (29) specific for MOMP, is capable of neutralizing in vitro infectivity of the parasite.
Because of the importance of MOMP in both the biology and immunology of the chlamydiae, we used recombinant DNA techniques to isolate the gene encoding the MOMP in order to more thoroughly describe the structure and function of this protein.
MATERIALS AND METHODS
Bacterial strains. The strains and plasmids which we used are listed in Table 1 . Escherichia coli strains were grown in LB medium (26) . C. trachomatis LGV-434 (serovar L2) was grown in L-cell suspension culture, and EBs were purified as described previously (7) .
Determination of amino acid sequence of MOMP. Outer membranes of C. trachomatis EBs were purified by using Sarkosyl solubilization, as described previously (7) . The Sarkosyl-insoluble pellet was then extracted with 1% octylglucopyranoside (Calbiochem-Behring, La Jolla, Calif.) in 50 mM sodium phosphate-20 mM EDTA-50 mM dithiothreitol (pH 7.2) at 50°C for 1 h. The mixture was centrifuged at 30,000 x g for 30 min, and the supernatant and pellet were 100 ,ug of proteinase K per ml at 37°C for at least 1 h. The entire cellular extract was subjected to cesium chloride-ethidium bromide buoyant density centrifugation, and the DNA band was recovered. Plasmid vector DNA was isolated by the method of Ish-Horowicz and Burke (23) , followed by cesium chloride-ethidium bromide purification. Plasmid DNA was further treated with RNase A and run over an NaCl gradient as previously described (27) .
DNA was recovered from agarose gels by using the method of Dretzen et al. (14) and was used in ligation reactions without further treatment.
Southern blots (32) on type BA85 nitrocellulose filters (Schleicher & Schuell, Inc., Keene, N.H.) were prehybridized in 5 x Denhardt solution (12) for 2 h at 20°C and hybridized with oligonucleotides (5 x 106 cpm) in 6x SSPE (11) for 16 h at 20°C. The unbound probe was removed by washing once in 6x SSPE at 20°C for 30 min and three times at 30°C for 5 min.
DNA restriction digestion and ligation were performed by standard techniques, using enzymes purchased from Bethesda Research Laboratories, Inc., Bethesda, Md., or New England BioLabs, Beverly, Mass. Transformation of E. coli to ampicillin resistance (50 ,ug/ml) was performed by using either a CaCl2 buffer (10) or a RbCl2 buffer (20) .
Calf intestinal alkaline phosphatase was purchased from P-L Biochemicals, Inc., Piscataway, N.J., and was used under the conditions specified by the manufacturer. A mixed oligonucleotide probe was synthesized by using a model SAM-1 instrument (Biosearch, San Rafael, Calif.) according to a protocol supplied by the manufacturer, using the reactions described by Efimov et al. (15, 16 
RESULTS
Determination of the amino acid sequence of the N terminus of the MOMP. Figure 1 shows the partial amino-terminal amino acid sequence of the MOMP of C. trachomatis. Approximately 5 nM MOMP was used in each sequencer analysis, and the sequence shown represents at least duplicate results for each position. In none of the three sequenator trials was the residue at position 10 identified. These samples were not fully reduced and alkylated, and since cysteine-phenylthiohydantoin derivatives are unstable under the conditions used, position 10 may represent a cysteine.
Construction of oligonucleotide probes. Knowledge of the amino acid sequence allowed us to design a family of oligonucleotides, one of which was predicted to hybridize to the 5' end of the antisense DNA strand of the MOMP gene. The degeneracy of the family of oligonucleotides was kept to a minimum by choosing the stretch of amino acids with the minimum degeneracy in their codons and by incorporating a guanosine residue in the third position of certain codons in place of a cytosine or adenosine residue (Fig. 1) . These substitutions allowed a neutral DNA-DNA hybridization reaction at these positions (34) and allowed the use of an 8-fold degenerate probe instead of the 72-fold degenerate probe required if all codons were included. Approximately 2 ,ug of this oligonucleotide mixture was labeled with 32P by using polynucleotide kinase and then used to probe a Southern blot of total genomic DNA isolated from C. trachomatis ( Fig. 2A) .
Isolation of a recombinant clone producing a 15-kd fragment of the chlamydial MOMP. We isolated a recombinant clone which produced a 15-kilodalton (kd) fragment of the chlamydial MOMP. C. trachomatis DNA that was doubly digested with BamHI and PstI showed the strongest hybridization signal at about 2 kilobases (kb) in a Southern blot hybridization ( Fig. 2A) . BamHI-PstI-digested DNA in this size range was recovered from an agarose gel and cloned into plasmids pEMBL8(+) and pEMBL9(+). Directional cloning into these two plasmids ensured that the cloned DNA could potentially be in both orientations with respect to the lac promoter on the pEMBL plasmids. We recovered one recombinant clone in pEMBL9(+) that reacted with a mixture of three monoclonal antibodies directed against the chlamydial MOMP (Fig. 2B) . The cloned 2.0-kb insertion was subcloned into pEMBL8(+) in order to reverse the insertion orientation. The original recombinant plasmid was Fig. 5 ), indicating that the amino-terminal end of MOMP is within 800 base pairs of the PstI end of the insertion (data not shown).
Expression products of pFEN1 and pFEN2. E. coli strains harboring pFEN1 produced a 15-kd polypeptide that reacted with type-specific monoclonal antibody directed against the Chlamydia sp. serovar L2 MOMP (Fig. 3) . Expression of the 15-kd polypeptide was constitutive and may have resulted from the lack of repression of the lac promoter on the multicopy plasmid. Alternatively, chlamydial promoters may have been the dominant transcriptional effectors, at least when the insertion was oriented as it was in pFEN1. E. coli strains harboring pFEN2 did not produce any polypeptide products that were reactive with antibody directed against the chlamydial MOMP but did produce a 35-kd peptide. Differential expression of the cloned insertion in the opposite orientation with respect to the lac promoter suggests that there is some role for plasmid promoters in expression of the cloned products and also suggests that the 15-and 35-kd products are transcribed in opposite directions.
We thought that the 15-kd immunologically reactive product resulted from a truncated MOMP gene and, therefore, that we could find an intact MOMP gene by using pFEN1 DNA as a hybridization probe. We cloned larger (>2.0-kb) PstI and HindlIl fragments of chlamydial DNA that hybridized to pFEN1 into both plasmid and bacteriophage vectors. In all cases, we detected no cloned protein products either by immunological screening or by Coomassie blue-or silverstained PAGE (data not shown).
Isolation of a recombinant clone producing a product reactive with subspecies-specific monoclonal antibody. In another approach to obtaining a recombinant clone of the MOMP gene, we constructed a pUC8 bank of C. trachomatis DNA. A partial Sau3A digest of chlamydial DNA was separated by agarose gel electrophoresis, and 4-to 6-kb DNA was collected and cloned into BamHI-digested, alkaline phosphatase-treated pUC8.
After screening the clone bank with a mixture of monoclonal antibodies, we isolated one recombinant clone that produced a 51-kd peptide which reacted with a subspeciesspecific monoclonal antibody (Fig. 4) but not with the type-specific or species-specific monoclonal antibody. The recombinant plasmid, which contained a 5.5-kb insertion, was designated pFEN6. When polyacrylamide gels were heavily loaded, peptides with molecular weights of about 27,000 and 33,000 which were not found in the parent strain were detected in E. coli strains harboring pFEN6 (Fig. 4C) .
The 33-kd peptide was probably a breakdown product of the 51-kd peptide since it reacted with the subspecies-specific monoclonal antibody (Fig. 4D) ; the nature of the 27-kd polypeptide is unknown. Addition of isopropyl-3-Dthiogalactopyranoside to cultures of strain JM109(pFEN6) increased the production of the 51-kd product.
Restriction maps of plasmids pFEN1 and pFEN6 are shown in Fig. 5 . DISCUSSION In this work, we used two different approaches to isolate recombinant clones of the C. trachomatis MOMP gene. In one approach, we determined the amino acid sequence of a portion of the MOMP in order to construct an oligonucleotide which could be used to probe chlamydial DNA. In order to guarantee a high degree of specificity, a probe needs to be at least 14 bases long for procaryotic genomes, and the degeneracy of the oligonucleotide probe is optimally kept low to reduce background noise. The serovar L2 MOMP sequence has two excellent probable sequences within the first 22 residues. The first extends from position 12 to position 16 and is 24-fold degenerate, whereas the second is located at positions 18 through 22 and is 16-fold degenerate. As with most amino acid sequences having low nucleotide degeneracy, each sequence contains either a methionine or a tryptophan.
Our use of the pEMBL plasmid series was designed to allow us to identify recombinant clones in the absence of any gene expression of the clone in E. coli. If necessary, we had the option of identifying a MOMP recombinant clone by its reaction with the oligonucleotide probe which we had constructed. Confirmation of a presumptive clone could be accomplished by DNA sequencing and alignment of the DNA sequence with the determined amino acid sequence.
The pEMBL plasmids facilitate rapid DNA sequencing since a single strand of the recombinant plasmid can be obtained by infection of the recombinant with a defective singlestranded bacteriophage (13) . However, our finding that pFEN1 made an antibody-reactive peptide obviated the need for DNA sequence analysis.
The second approach (use of monoclonal antibodies in the primary screening) also yielded a recombinant clone containing a portion of the MOMP gene. This recombinant clone apparently codes for a different portion of the MOMP, as determined by its reaction with the subspecies-specific mono- clonal antibody but not the type-specific monoclonal antibody. The size of the peptides made from the recombinant clones suggests that most, if not all, of the MOMP gene is contained within the two recombinant clones. Presumably in pFEN6, a fusion to the lacZ' gene would result in the addition of 15 kd to a cloned product; this would leave 36 kd attributable to the cloned peptide. The failure of the products from both pFEN1 and pFEN6 to react with the speciesspecific monoclonal antibody cannot be explained by our data; however, the specific reactivities of the cloned products with different monoclonal antibodies may prove useful in mapping chlamydial MOMP epitopes.
The complex expression properties of the chlamydial genes contained in pFEN1 may help elucidate gene expression in C. trachomatis when further genetic analysis is completed. It is difficult to ascertain at present whether the gene expression observed in E. coli reflects gene expression in C. trachomatis or whether the expression patterns are an artifact of the recombinant clone.
We have begun DNA sequence analysis of pFEN1 and pFEN6. This type of analysis may help answer questions about gene expression and location of epitopes, as well as allow precise manipulation of the MOMP gene. Our knowledge of a portion of the amino acid sequence of MOMP will aid us in determining the correct reading frame of the DNA sequence, as well as serve as a measure of accuracy of the DNA sequence.
Recently, Allan and co-workers (1) isolated a recombinant bacteriophage that produced two peptides (40 and 41 kd), both of which reacted with serum from a patient with a C. trachomatis serovar Li infection; the target DNA was isolated from C. trachomatis serovar Li. The data which these workers present suggest that they cloned an intact MOMP gene. Their use of a bacteriophage vector may have avoided problems of toxic effects of expression of an intact MOMP gene that might be present when a plasmid vector system is used. LITERATURE CITED
